Eklonia cava extract has been scientifically proven to help your… CHOLESTEROL & HEART: One recent study indicates that it can help lower LDL cholesterol and your triglycerides in as little as eight weeks. BLOOD FLOW & CIRCULATION: Improve blood flow to your heart and brain in as few as six weeks and enhance circulation. MENTAL FOCUS: In an acute dosage study, it helped boost alpha waves, which are associated with increased mental acuity, and is also one of the few natural substances that crosses the blood/brain barrier and provides antioxidant protection for your brain. JOINTS: Soothe stiff, sore joints and ease everyday joint aches and discomfort without risky side effects. ENERGY: Flood your body with natural energy and keep yourself more alert, even after long hours or long days. Here are some of Eklonia cava extract’s many, unique health benefits… 1) Supports healthy Blood Glucose levels Conditions such as Metabolic syndrome, Syndrome X, diabetes and other blood glucose related conditions are increasing at epidemic proportions in the United States. A recent Harvard (Joslin School of Diabetes) mouse study directly implicates excessive fat deposits within the mouse pancreas as turning on the NF-kappa B inflammation pathway, resulting in full-blown type II diabetes and insulin insensitivity in the mice. Compounds found within Eklonia cava extract have been found to be very potent aldose reductase inhibitors, which may be of benefit to help support healthy blood glucose levels. 2) Helps lower your bad cholesterol and raise your good cholesterol. The research suggests that Eklonia cava extract may be one of the most effective natural solutions ever seen for cholesterol concerns. Eklonia cava extract works wonders for your cholesterol in two ways: First, its strong antioxidant abilities scavenge cholesterol in your body, helping to reduce the oxidation of LDL cholesterol; and Second, recent studies suggest that Eklonia cava extract helps lower cholesterol and triglycerides. In one open-label study, 39 adults with an average age of 56 took 300 mg of Eklonia cava extract a day for six weeks. Incredibly, they experienced a decrease in LDL cholesterol and triglycerides—and an increase in HDL “good” cholesterol. Individual results will certainly vary, but this research against baseline shows that Eklonia cava extract may be a powerful tool in promoting normal cholesterol as part of a heart health program. But that’s not all. Eklonia cava extract also… 2) Supports enhanced brain health Because Eklonia cava extract crosses the blood/brain barrier to give your brain critical antioxidant protection against free radicals and further supports superior brain in four very unique ways… It’s a unique antioxidant that crosses the blood/brain barrier to give your brain added antioxidant protection against free radicals. It helps increase your brain alpha waves, a good indication of relaxing blood vessels to your brain and promoting brain activity. Recent research suggests that Eklonia cava extract helps to stimulate the production of acetylcholine, the brain chemical that allows you to remember and learn. Eklonia cava extract enhances blood flow and circulation. Because Eklonia cava extract supplies your body with the most powerful antioxidants on earth, providing your body with up to 100 times greater antioxidant power than any other land-based antioxidants, Eklonia cava extract nourishes your brain to boost your mental alertness and acuity. Preliminary animal studies suggest that it stimulates the production of the neurotransmitter acetylcholine in the brain. Acetylcholine is the brain chemical that allows you to remember and learn—and the more, the better. Most importantly, Eklonia cava extract helps more blood, nutrients, and oxygen get to your brain faster so you think clearer and sharper. 3) Cardiovascular benefits- supports healthy circulation throughout the body Besides protecting your body with the most powerful antioxidants on Earth, Eklonia cava extract has the unique ability to enhance your circulation and blood flow. It does so by helping your blood vessels naturally dilate and get larger, for smoother blood flow and helps keep the thin endothelial lining of your blood vessels healthy, ensuring an easy flow of nutrient-rich blood throughout your body. It also helps regenerate nitric oxide, which signals the smooth muscles in your blood vessels to relax, resulting in increased blood flow naturally inhibits the angiotensin converting enzyme, called ACE, which tends to rise with age and contributes to blood vessel constriction. Scientific evidence supports Eklonia cava extract’s ability to improve your blood flow. As referenced above, Dr. Haengwoo Lee, one of the researchers who discovered Eklonia cava, found that it increased the velocity of blood from 36.68 cm/sec to 40.09 cm/sec, a good indicator of smoother flowing blood. In addition, a study at Yonsei University in Seoul, Korea noted that after six weeks of Ecklonia cava, blood flow dilation and nitric oxide activity in the blood vessels improved. There can be no question: Proper blood flow to your brain means you’ll increase mental sharpness and alertness!! 4) Substantially reduces inflammation Dr. Lee and his colleagues found that Eklonia cava naturally suppress inflammatory responses and neutralize inflammatory damage caused by reactive oxygen species. Its natural anti-inflammatory and tissue-protective properties appear to enable dramatic improvement in many conditions caused or influenced by inflammation. Eklonia cava extract extract’s ability to significantly impact systemic pain and discomfort was found to be comparable to Celebrex®, the controversial prescription drug that reduces inflammatory cox enzymes. 5) Supports superior Erectile Function Scientists studied 31 men’s’ erectile function for over six months. They compared eight weeks of Eklonia cava extract use to Viagra®. The researchers looked at orgasmic function, intercourse satisfaction, overall satisfaction, and erectile function. Eklonia cava extract performed better than Viagra® in virtually all parameters. No side effects were reported with ECE. See results below: ECE Scores: Viagra® Scores: Orgasmic Function 87% Orgasmic Function 27% Intercourse Satisfaction 74% Intercourse Satisfaction 44% Overall Satisfaction 62% Overall Satisfaction 39% Erectile Function 66% Erectile Function 66% These results strongly indicate that the long-term administration of Eklonia cava extract significantly contributes to the neutralization of oxidative risk factors, thereby improving peripheral blood circulation around muscles and nerves involved in sexual function as well as the penile artery. These results confirm that ECE can rejuvenate damaged endothelial cells to produce NO. Interestingly, Viagra® works by increasing NO in the penile artery.)
6) Eklonia cava extract helps soothe stiff joints and everyday aches and pains In a double-blind, placebo controlled trial indicates that Eklonia cava extract can soothe stiff joints and everyday aches and pain. Those taking 600 mg of Eklonia cava extract a day for 12 weeks noticed a real difference in their joint health. They experienced less discomfort compared to those taking the placebo.
REFERENCES: • “Composition For Prevention And Improvement Of Dementia And Promotion Of Memory, And Healthy Assistance Foodstuffs Containing The Composition” Korean Patent Application# 10-2003-88177 (Assigned To Haengwoo Lee). • “Compound For Improving Hypertension Containing Inhibitors Of Angiotensin Converting Enzyme Activity Extracted From Marin Plants And Articles Comprising Thereof”, Korean Patent Application 10-2004-24347 (Livechem, Inc). • “Compound For Improving Neuralgia Containing Dibenzo-P-Dioxine Derivatives Extracted From Marine Plants And Articles Comprising Thereof”. Korean Patent Application 10-2004-0028066 (Livechem, Inc). • Ahn MJ, Yoon KD, Min SY, Lee JS, Kim JH, Kim TG, Kim SH, Kim NG, Huh H, Kim J. Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava. Biol Pharm Bull. 2004 Apr;27(4):544-7. • Aikawa, T., S. Shimura, H. Sasaki, M. Ebina, And T. Takishima. 1992. Marked Goblet Cell Hyperplasia With Mucus Accumulation In The Airways Of Patients Who Died Of Severe Acute Asthma Attack. Chest 101:916-921. • Athukorala Y, Kim KN, Jeon YJ. Antiproliferative and antioxidant properties of an enzymatic hydrolysate from brown alga, Ecklonia cava. Food Chem Toxicol. 2006 Jul;44(7):1065-74. Epub 2006 Mar 3. • Becker AJ, Uckert S, Stief CG, Scheller F, Knapp WH, Hartmann U, Jonas U. Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. Urology. 2001 Nov;58(5):805-10. • Becker AJ, Uckert S, Stief CG, Truss MC, Machtens S, Scheller F, Knapp WH, Hartmann U, Jonas U. Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence. Urology. 2001 Jan;57(1):193-8. • Cases S, Smith SJ, Zheng YW, Myers HM, Lear SR, Sande E, Novak S, Collins C, Welch CB, Lusis AJ, Erickson SK, Farese RV Jr. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13018-23. • Chapman VJ, Chapman DJ. (1980). Seaweeds and their uses. London: Chapman & Hall. • De Angelis L, Marfella MA, Siniscalchi M, Marino L, Nappo F, Giugliano F, De Lucia D, Giugliano D. Erectile and endothelial dysfunction in Type II diabetes: a possible link. Diabetologia. 2001 Sep;44(9):1155-60. • Djukanovic, R., J.W. Wilson, K.M. Britten, S.J. Wilson, A.F. Walls, W.R. Roche, P.H. Howarth, S.T. Holgate. 1990. Quantitation Of Mast Cells And Eosinophils In The Bronchial Mucosal Of Symptomatic Atopic Asthmatics And Healthy Control Subjects Using Immunohistochemistry. Am.Rev.Respir.Dis. 142:863-871. • Dorrance AM, Lewis RW, Mills TM. “Captopril Treatment Reverses Erectile Dysfunction In Male Stroke Prone Spontaneously Hypertensive Rats.” Int J Impot Res. 2002 Dec;14(6):494-7 • Fukuyama Y, Kodama M, Miura I, Kinzyo Z, Mori H, Nakayama Y, Takahashi M. Anti-plasmin inhibitor. VI. Structure of phlorofucofuroeckol A, a novel phlorotannin with both dibenzo-1,4-dioxin and dibenzofuran elements, from Ecklonia kurome Okamura. Chem Pharm Bull (Tokyo). 1990 Jan;38(1):133-5. • Fukuyama, Y., Kodama, M., Miura, I., Kinzyo, Z., Kido, M., Mori, H., Nakayama, Y., Takahashi, M. Structure Of An Anti-Plasmin Inhibitor, Eckol, Isolated From The Brown Alga Ecklonia Kurome Okamura And Inhibitory Activities Of Its Derivatives On Plasmin Inhibitors. Chem. Pharm. Bull. 37: 349-353 (1989) • Glombitza, K.W., Gerstberger, G. Phlorotannins With Dibenzodioxin Structural Elements From The Brown Alga Eisenia Arborea. Phytochemistry 24: 543-551 (1985) • Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, Corry DB. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998 Dec 18;282(5397):2261-3. • Hamed EA, Meki AR, Gaafar AA, Hamed SA. Role Of Some Vasoactive Mediators In Patients With Erectile Dysfunction: Their Relationship With Angiotensin-Converting Enzyme And Growth Hormone. Int J Impot Res. 2003 Dec;15(6):418-25. • Henderson, W.R., E.Y. Chi. 1985. Ultrastructural Characterization And Morphometric Analysis Of Human Eosinophil Degranulation. J. Cell Sci. 73:33-48. • Henderson, W.R., Jr., D.B. Lewis, R.K. Albert, Y. Zhang, W.J.E. Lamm, G.K.S. Chiang, F. Jones, P. Eriksen, Y. Tien, M. Jonas, E.Y. Chi. 1996. The Importance Of Leukotrienes In Airway Inflammation In A Mouse Model Of Asthma. J. Exp. Med. 184:1483-1494. • Henderson, W.R., Jr., E.Y. Chi, C.R. Maliszewski. 2000. Soluble Interleukin-4 Receptor (Sil-4R) Inhibits Airway Inflammation Following Allergen Challenge In A Mouse Model Of Asthma. J. Immunol. 164:1086-1095. • Hoppe HA. (1979). Marine algae and their products and constituents in pharmacy. In: Marine Algae in Pharmaceutical Science. Hoppe HA, Levring T, Tanaka Y, eds. Berlin & New York: Walter de Gruyter. • Hoshino, M., Y. Nakamura, J.J. Sim. 1998. Expression Of Growth Factors And Remodeling Of The Airway Wall In Bronchial Asthma. Thorax 53:21-27. • Kang K, Park Y, Hwang HJ, Kim SH, Lee JG, Shin HC. Antioxidative properties of brown algae polyphenolics and their perspectives as chemopreventive agents against vascular risk factors. Arch Pharm Res. 2003 Apr;26(4):286-93. • Kang KA, Lee KH, Chae S, Koh YS, Yoo BS, Kim JH, Ham YM, Baik JS, Lee NH, Hyun JW. Triphlorethol-A from Ecklonia cava protects V79-4 lung fibroblast against hydrogen peroxide induced cell damage. Free Radic Res. 2005 Aug;39(8):883-92. • Kang KA, Lee KH, Chae S, Zhang R, Jung MS, Ham YM, Baik JS, Lee NH, Hyun JW. Cytoprotective effect of phloroglucinol on oxidative stress induced cell damage via catalase activation. J Cell Biochem. 2006 Feb 15;97(3):609-20. • Kang KA, Lee KH, Chae S, Zhang R, Jung MS, Lee Y, Kim SY, Kim HS, Joo HG, Park JW, Ham YM, Lee NH, Hyun JW. Eckol isolated from Ecklonia cava attenuates oxidative stress induced cell damage in lung fibroblast cells. FEBS Lett. 2005 Nov 21;579(28):6295-304. Epub 2005 Oct 19. • Kang KA, Zhang R, Lee KH, Chae S, Kim BJ, Kwak YS, Park JW, Lee NH, Hyun JW. Protective effect of triphlorethol-A from Ecklonia cava against ionizing radiation in vitro. J Radiat Res (Tokyo). 2006 Mar;47(1):61-8. • Kang, K., Park, Y., Hwang, H. J., Kim, S. H., Lee, J. G., Shin, H.-C. (2003). Antioxidative Properties Of Brown Algae Polyphenolics And Their Perspectives As Chemopreventive Agents Against Vascular Risk Factors. Arch. Pharm. Res.. 26: 286-293 • Kang, K.J., Hwang, H.J., Hong, D.H., Park, Y.J., Kim, S,H., Lee, B.H., Shin, H.C. Anti-Oxidant And Anti-Inflammatory Activities Of Ventol, A Phlorotannin-Rich Natural Agent Derived From Ecklonia Cava, And Its Effect On Proteoglycan Degradation In Cartilage Explant Culture. Submitted To Molecular Pathology And Pharmacology • Kay, A.B. 1997. T Cells As Orchestrators Of The Asthmatic Response. Ciba Found. Symp. 206:56-67. • Kim MM, Ta QV, Mendis E, Rajapakse N, Jung WK, Byun HG, Jeon YJ, Kim SK. Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity. Life Sci. 2006 Sep 5;79(15):1436-43. Epub 2006 May 7. • Krug, N., J. Madden, A.E. Redington, P. Lackie, R. Djukanovic, U. Schauer, S.T. Holgate, A.J. Frew, P.H. Howarth. 1996. T-Cell Cytokine Profile Evaluated At The Single Cell Level In Bal And Blood In Allergic Asthma. Am. J. Respir. Cell Mol. Biol. 14:319-326. • Lee, B.H., Stein, S. Improvement Of Learning Behavior Of Mice By An Antiacetylcholinesterase And Neuroprotective Agent Nx42, A Laminariales-Alga Extract. Presented To The Pharm. Soc. Kor., Spring Conference (2004); Manuscript Submitted To Korean Journal Of Food Science And Technology. • Lee, S.H., Han, S.B., Baik, J.Y. The Influence Of VNP Intake On The Symptoms Of Osteoarthritis Of The Knee Joint. Clinical Report By Department Of Orthopedic Surgery, Anam Hospital, Korea University Medical Center • Mcever, R.P. 1991. Selectins: Novel Receptors That Mediate Leukocyte Adhesion During Inflammation. Thromb. Haemost. 65:223-228. • Myung CS, Shin HC, Bao HY, Yeo SJ, Lee BH, Kang JS. Improvement of memory by dieckol and phlorofucofuroeckol in ethanol-treated mice: possible involvement of the inhibition of acetylcholinesterase. Arch Pharm Res. 2005 Jun;28(6):691-8. • Nakamura, T., Nagayama, K., Uchida, K., Tanaka, R. Antioxidant Activity Of Phlorotannins Isolated From The Brown Alga Eisenia Bicyclis. Fisheries Sci. 62: 923-926 (1996). • Roche, W.R., R. Beasley, J.H. Williams, S.T. Holgate. 1989. Subepithelial Fibrosis In The Bronchi Of Asthmatics. Lance 1:520-524. • Ruehl ML, Orozco JA, Stoker MB, Mcdonagh PF, Coull BM, Ritter LS. Protective Effects Of Inhibiting Both Blood And Vascular Selectins After Stroke And Reperfusion. Neurol Res. 2002 Apr;24(3):226-32. • Sheehan, D.C., B.B. Hrapchak. 1980. Connective Tissue/Muscle Fiber Stains. In Theory And Practice Of Histotechnology. Battelle Press, Columbus, OH. 180-201. • Shibata, T., Fujimoto, K., Nagayama, K., Yamaguchi, K., Nakamura, T. Inhibitory Activity Of Brown Algal Phlorotannins Against Hyaluronidase. Int. J. Food Sci. Tech. 37: 703-709 (2002) • Shibata, T., Nagayama, K., Tanaka, R., Yamaguchi, K., Nakamura, T. Inhibitory Effects Of Brown Algal Phlorotannins On Secretory Phospholipase A2S, Lipoxygenases And Cycloxygenases. J. Appl. Phycol. 15: 61-66 (2003) • Shin HC, Hwang HJ, Kang KJ, Lee BH. An antioxidative and antiinflammatory agent for potential treatment of osteoarthritis from Ecklonia cava. Arch Pharm Res. 2006 Feb;29(2):165-71. • Smith SJ, Cases S, Jensen DR, Chen HC, Sande E, Tow B, Sanan DA, Raber J, Eckel RH, Farese RV Jr. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet. 2000 May;25(1):87-90. • Temann UA, Prasad B, Gallup MW, Basbaum C, Ho SB, Flavell RA, Rankin JA. A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am J Respir Cell Mol Biol. 1997 Apr;16(4):471-8. • Tsukada H, Nishiyama S, Fukumoto D, Ohba H, Sato K, Kakiuchi T. Effects of acute acetylcholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: Functional imaging of the conscious monkey brain using animal PET in combination with microdialysis. Synapse. 2004 Apr;52(1):1-10. • Uhm CS, Kim KB, Lim JH, Pee DH, Kim YH, Kim H, Eun BL, Tockgo YC. Effective treatment with fucoidin for perinatal hypoxic-ischemic encephalopathy in rats. Neurosci Lett. 2003 Dec 15;353(1):21-4. • Virag R, Floresco J, Richard C. Impairment Of Shear-Stress-Mediated Vasodilation Of Cavernous Arteries In Erectile Dysfunction. Int J Impot Res. 2004 Jan;16(1):39-42 • Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T.Y. Neben, C.L. Karp, D.D. Donaldson. 1998. Interleukin-13: Central Mediator Of Allergic Asthma. Science 282:2258-2261. • Zhu, Z., R.J. Homer, Z. Wang, Q. Chen, G.P. Geba, J. Wang, Y. Zhang, J.A. Elias. 1999. Pulmonary Expression Of Interleukin-13 Causes Inflammation, Mucus Hypersecretion, Subepithelial Fibrosis, Physiologic Abnormalities, And Eotaxin Production. J. Clin. Invest. 103:779-788.